Related references
Note: Only part of the references are listed.Human RBP4 adipose tissue expression is gender specific and influenced by leptin
Katarina Kos et al.
CLINICAL ENDOCRINOLOGY (2011)
Non-alcoholic fatty liver disease
Briohny W. Smith et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2011)
FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women
Ximena Terra et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
RBP4: a controversial adipokine
Primoz Kotnik et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Retinol-Binding Protein 4 and New Adipocytokines in Nonalcoholic Fatty Liver Disease
Anke Toenjes et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
Cem Cengiz et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
Elisa Fabbrini et al.
HEPATOLOGY (2010)
The autocrine and paracrine roles of adipokines
Kalypso Karastergiou et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Expression of Neuropeptide Y, Omentin and Visfatin in Visceral and Subcutaneous Adipose Tissues in Humans: Relation to Endocrine and Clinical Parameters
Stephanie Barth et al.
OBESITY FACTS (2010)
Association of Retinol-Binding Protein-4 (RBP4) with Lipid Parameters in Obese Women
Montserrat Broch et al.
OBESITY SURGERY (2010)
Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation
Alexander Koch et al.
CRITICAL CARE (2010)
Role of adipokines in complications related to obesity. A review
M. Gnacinska et al.
ADVANCES IN MEDICAL SCIENCES (2009)
Nonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines
Stergios A. Polyzos et al.
CURRENT MOLECULAR MEDICINE (2009)
Parallel downregulation of retinol-binding protein-4 and adiponectin expression in subcutaneous adipose tissue of non-morbidly obese subjects
Montserrat Broch et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Adipocyte Fatty Acid Binding Protein Levels Relate to Inflammation and Fibrosis in Nonalcoholic Fatty Liver Disease
Kerry-Lee Milner et al.
HEPATOLOGY (2009)
Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease
Maria Schina et al.
HEPATOLOGY RESEARCH (2009)
Serum Retinol-binding Protein 4 Levels in Patients With Nonalcoholic Fatty Liver Disease
Naim Alkhouri et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease
J. A. Seo et al.
CLINICAL ENDOCRINOLOGY (2008)
Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
Haiya Wu et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Elevated serum retinol-binding protein 4 concentrations are associated with renal dysfunction and uric acid in type 2 diabetic patients
Yu-Hung Chang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2008)
Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass
Nora Kloeting et al.
CELL METABOLISM (2007)
High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans
Norbert Stefan et al.
DIABETES CARE (2007)
Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes
Young Min Cho et al.
DIABETES CARE (2006)
Retinol-binding protein 4 in human obesity
Juergen Janke et al.
DIABETES (2006)
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects
Timothy E. Graham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Q Yang et al.
NATURE (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Beyond insulin resistance in NASH:: TNF-α or adiponectin?
JM Hui et al.
HEPATOLOGY (2004)
The epidemiology of fatty liver
S Bellentani et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2004)
The role of extrahepatic retinol binding protein in the mobilization of retinoid stores
L Quadro et al.
JOURNAL OF LIPID RESEARCH (2004)
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini et al.
HEPATOLOGY (2003)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)